Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bis(?-4,4;6,6-bis-(biphenyl-2,2'-diyldi-oxy)-2,2-bis-{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen-oxy}cyclo-triphosphazene)di-?-chlorido-bis-[chlorido-copper(II)].

ABSTRACT: In the crystal of the title compound, [Cu(2)Cl(4)(C(50)H(32)N(9)O(8)P(3))(2)], the binuclear mol-ecule is located across an inversion center. Each Cu(2+) cation is coordinated by two pyridine N atoms from symmetry-related 4,4;6,6-bis-(biphenyl-2,2'-diyldi-oxy)-2,2-bis-{2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]phen-oxy}cyclo-triphosphazene (L) ligands, a pair of bridging Cl(-) anions and a terminal Cl(-) anion, forming a distorted CuCl(3)N(2) square-pyramidal geometry. Weak intra-molecular C-H?O and inter-molecular C-H?N inter-actions occur in the crystal.

SUBMITTER: Wu XW

PROVIDER: S-EPMC3344371 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Diethyl 2,2'-(biphenyl-2,2'-diyldi-oxy)diacetate.

Project description:In the title compound, C(20)H(22)O(6), the mean planes through the benzene rings make a dihedral angle of 59.82?(7)° with each other. Weak inter-molecular C-H?O inter-actions together with ?-? stacking inter-actions [centroid-centroid distance = 3.830?(1)?Å] between benzene rings are observed in the crystal packing.

| S-EPMC3007496 | biostudies-literature

1,4-Bis{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}butane.

Project description:In the centrosymmetric title compound, C(18)H(16)N(6)O(2)S(2), the 1,3,4-oxadiazole and the attached pyridinyl ring are twisted by 5.3?(3)°.

| S-EPMC3052088 | biostudies-literature

1,3-Bis{[5-(pyridin-2-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}propan-2-one.

Project description:In the distorted W-shaped mol-ecule of the title compound, C(17)H(12)N(6)O(3)S(2), a twofold axis passes through the carbonyl group. The mol-ecules stack in the crystal through ?-? inter-actions [centroid-centroid distance = 3.883?Å] and weak C-H?N hydrogen-bonding inter-actions, forming a three-dimensional architecture.

| S-EPMC3051430 | biostudies-literature

2,2'-(Biphenyl-2,2'-diyldi-oxy)diaceto-hydrazide.

Project description:In the mol-ecule of the title compound, C(16)H(18)N(4)O(4), the dihedral angle between the mean planes of the two benzene rings is 56.76?(5)°. The crystal structure reveals extensive inter-molecular hydrogen bonds between carbonyl O atoms and primary amines, as well as between primary and secondary amines of hydrazide, forming rings of R(2) (2)(10) and R(2) (2)(6) motifs, respectively. The structure is further stabilized by intra-molecular and non-classical hydrogen bonds of the types N-H?O and C-H?O, respectively. The structure does not show any ?-? inter-actions.

| S-EPMC2961455 | biostudies-other

Tetra-aqua-bis-(2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}acetato)-cobalt(II) monohydrate.

Project description:In the title compound, [Co(C(9)H(6)N(3)O(3)S)(2)(H(2)O)(4)]·H(2)O, the two 2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}acetate ligands are monodentate. One coordinates the metal atom via the pyridyl N atom whereas the other coordinates via the carboxyl-ate O atom. The Co(II) atom adopts a slightly distorted octa-hedral coordination geometry with four O atoms of the coordinated water mol-ecules located in the equatorial plane and the N and O atoms of the two POA ligands in axial positions. In the crystal, the components are connected through O-H?O and O-H?N hydrogen bonds into a three-dimensional framework.

| S-EPMC3238654 | biostudies-literature

4-[5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl]pyridinium benzoate.

Project description:In the title compound, C(12)H(9)N(4)O(+)·C(7)H(5)O(2) (-), π-π stacking inter-actions [centroid-centroid distance = 3.6275 (14) Å] stabilize the crystal structure. The dihedral angles between the central ring and the terminal rings are 3.27 (12) and 10.30 (13)°.

| S-EPMC3051668 | biostudies-literature

catena-Poly[[diaqua-nickel(II)]-bis-(μ-2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}acetato)].

Project description:In the title compound, [Ni(C(9)H(6)N(3)O(3)S)(2)(H(2)O)(2)](n), the Ni(II) atom, located on an inversion center, is ligated in an octa-hedral geometry by two carboxyl-ate O atoms from two 2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfan-yl}acetate (L) ligands and two O atoms from water mol-ecules in the equatorial plane, and two pyridine N atoms from other two L ligands at the apical sites. Two L ligands bridge pairs of metal atoms in an anti-parallel manner, forming centrosymmetric dinuclear quasi-recta-ngular units which are linked into infinite double-stranded chains parallel to [100]. O-H⋯O hydrogen bonds between the coordinating water mol-ecules and the carboxyl-ate groups of the L ligand as well as interchain S⋯N inter-actions [2.726 (2)-3.363 (2) Å] lead to the formation of a layer structure parallel to (001).

| S-EPMC3379099 | biostudies-literature

[2,2'-Bis(pyridin-2-ylmeth-oxy)biphenyl-κN,O,O',N']bis-(nitrato-κO,O')cadmium.

Project description:In the title compound, [Cd(NO(3))(2)(C(24)H(20)N(2)O(2))], the Cd(II) ion is eight-coordinated by one ligand and two nitrate ions. There are C-H⋯O hydrogen bonds and C-H⋯π inter-actions and π-π inter-actions [centroid-centroid distance = 3.319 (1) Å] in the crystal structure.

| S-EPMC3246921 | biostudies-literature

3,3'-{[(Biphenyl-2,2'-di-yl)bis-(methyl-ene)]bis-(-oxy)}bis-[N-(4-chloro-phen-yl)benzamide].

Project description:In the title compound, C40H30Cl2N2O4, the two benzene rings of the biphenyl unit are twisted with respect to each other, making a dihedral angle of 73.07 (4)°. The benzene rings of the benzamide groups form dihedral angles of 77.09 (5) and 55.48 (6)° with the central biphenyl moiety. In the crystal, mol-ecules are linked through N-H⋯O hydrogen bonds to form a fused R 2 (2)(38) ring motif which forms a supermolecular ribbon network extending along the [100] plane. In the two 4-chloro-phenyl rings, the five C atoms and their attached H atoms are disordered over two sets of sites, with site-occupancy factors of 0.657 (15):0.343 (15) and 0.509 (13):0.491 (13).

| S-EPMC3685066 | biostudies-literature

2,2'-(Biphenyl-4,4'-diyldi-oxy)diacetic acid N,N-dimethyl-formamide solvate.

Project description:In the crystal struture of the title compound, C(16)H(14)O(6)·C(3)H(7)NO, the two crystallographically independent benzene rings are coplanar [dihedral angle = 1.00?(2)°]. The crystal structure is stabilized by O-H?O hydrogen bonds between the diacid and the solvate dimethylformamide mol-ecule, resulting in the formation of a zigzag chain structure extending parallel to [001].

| S-EPMC2977266 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data